| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7629914 | Journal of Pharmaceutical and Biomedical Analysis | 2015 | 32 Pages |
Abstract
- Mass spectrometry, nuclear magnetic resonance and chemometrics have enabled cancer biomarker discovery.
- Metabolomics can non-invasively identify biomarkers for diagnosis, prognosis and treatment of cancer.
- All major types of cancers and their biomarkers discovered by metabolomics have been discussed.
- This review sheds light on the pitfalls and potentials of metabolomics with respect to oncology.
Related Topics
Physical Sciences and Engineering
Chemistry
Analytical Chemistry
Authors
Seema Patel, Shadab Ahmed,